WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998000711) DETECTION OF CANCER BY ASSAYING FOR CANCER-SPECIFIC ANTIGENS HAVING LINKED OLIGOSACCHARIDES WHICH ARE AT LEAST TRIANTENNARY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/000711    International Application No.:    PCT/US1997/010444
Publication Date: 08.01.1998 International Filing Date: 13.06.1997
Chapter 2 Demand Filed:    07.01.1998    
IPC:
G01N 33/574 (2006.01)
Applicants: MILLENIUM PHARMACEUTICALS, INC. [US/US]; 640 Memorial Drive, Cambridge, MA 02129-4815 (US)
Inventors: ROBBINS, Phillips, W.; (US).
PRAKASH, Sadhana; (US)
Agent: LILLIE, Raymond, J.; Carella, Byrne, Bain, Gilfillan, Cecchi, Stewart & Olstein, 6 Becker Farm Road, Roseland, NJ 07068 (US)
Priority Data:
60/021,109 03.07.1996 US
Title (EN) DETECTION OF CANCER BY ASSAYING FOR CANCER-SPECIFIC ANTIGENS HAVING LINKED OLIGOSACCHARIDES WHICH ARE AT LEAST TRIANTENNARY
(FR) DEPISTAGE DU CANCER PAR ANALYSE DE RECHERCHE D'ANTIGENES SPECIFIQUES DU CANCER PRESENTANT DES OLIGOSACCHARIDES LIES QUI SONT AU MOINS TRIANTENNAIRES
Abstract: front page image
(EN)A process for assaying for cancer of the prostate, comprising assaying a sample derived from a human for prostate specific antigen having a linked oligosaccharide which is at least triantennary. The assay may employ a binding molecule which binds to oligosaccharides that are at least triantennary, but does not bind to oligosaccharides that are monoantennary or diantennary. Such binding molecule may be a lectin such as PHA-L or an antibody to an oligosaccharide that is at least triantennary.
(FR)L'invention concerne un procédé de dépistage par analyse du cancer de la prostate, consistant à analyser un échantillon prélevé chez un homme pour y rechercher un antigène spécifique de la prostate possédant un oligosaccharide lié qui est au moins triantennaire. Pour réaliser l'analyse, on peut utiliser une molécule de fixation qui se fixe aux oligosaccharides qui sont au moins triantennaires, mais qui ne se fixent pas aux oligosaccharides qui sont monoantennaires ou biantennaires. De telles molécules de fixation peuvent être la léctine telle que PHA-L ou un anticorps dirigé contre un oligosaccharide qui est au moins triantennaire.
Designated States: AU, CA, JP.
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)